EARLY Study: Evaluating the Specificity and Feasibility of the EARLY Biomarker Panel for Ovarian Cancer Detection

The overall aim of the EARLY study is to systematically evaluate the impact of blood collection protocols, storage temperatures, transport conditions, and time to processing on the stability of extracellular vesicle (EV) biomarkers associated with ovarian cancer, with the potential to inform and improve future ovarian cancer screening practices. This prospective study will inform future screening studies by: 1. Assessing the feasibility of participant recruitment and blood sample collection for extracellular vesicle analysis in a real-world healthcare setting, including evaluation of the pra

Trial Details

NCT ID
NCT07491081
Phase
NA
Sponsor
Queensland Centre for Gynaecological Cancer
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • Intervention 1
  • Intervention 2
Locations (sample)
  • Brisbane, Queensland, Australia|-27.46794,153.02809
  • Brisbane, Queensland, Australia|-27.46794,153.02809

Key Eligibility Criteria

  • Age between 50 and 74 years (inclusive).
  • Postmenopausal status, defined as either:
  • 1. At least 12 consecutive months of amenorrhoea following natural menopause or hysterectomy, or 2.2. At least 12 months of hormone replacement the…
  • Signed written informed consent.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →